Preclinical evaluation of the breast cancer cell-binding peptide, p160.
Askoxylakis V, Zitzmann S, Mier W, Graham K, Krämer S, von Wegner F, Fink RH, Schwab M, Eisenhut M, Haberkorn U.
Askoxylakis V, et al. Among authors: eisenhut m.
Clin Cancer Res. 2005 Sep 15;11(18):6705-12. doi: 10.1158/1078-0432.CCR-05-0432.
Clin Cancer Res. 2005.
PMID: 16166451